BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 10535448)

  • 1. Oral administration of cholera toxin B-insulin conjugates protects NOD mice from autoimmune diabetes by inducing CD4+ regulatory T-cells.
    Ploix C; Bergerot I; Durand A; Czerkinsky C; Holmgren J; Thivolet C
    Diabetes; 1999 Nov; 48(11):2150-6. PubMed ID: 10535448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasal administration of CTB-insulin induces active tolerance against autoimmune diabetes in non-obese diabetic (NOD) mice.
    Aspord C; Thivolet C
    Clin Exp Immunol; 2002 Nov; 130(2):204-11. PubMed ID: 12390307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against autoimmune diabetes with oral insulin is associated with the presence of IL-4 type 2 T-cells in the pancreas and pancreatic lymph nodes.
    Ploix C; Bergerot I; Fabien N; Perche S; Moulin V; Thivolet C
    Diabetes; 1998 Jan; 47(1):39-44. PubMed ID: 9421372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes.
    Bergerot I; Ploix C; Petersen J; Moulin V; Rask C; Fabien N; Lindblad M; Mayer A; Czerkinsky C; Holmgren J; Thivolet C
    Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4610-4. PubMed ID: 9114038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. alpha4 integrins and L-selectin differently orchestrate T-cell activity during diabetes prevention following oral administration of CTB-insulin.
    Aspord C; Czerkinsky C; Durand A; Stefanutti A; Thivolet C
    J Autoimmun; 2002 Dec; 19(4):223-32. PubMed ID: 12473243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced immunological tolerance against allograft rejection by oral administration of allogeneic antigen linked to cholera toxin B subunit.
    Sun JB; Li BL; Czerkinsky C; Holmgren J
    Clin Immunol; 2000 Nov; 97(2):130-9. PubMed ID: 11027453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cholera toxin B subunit is a mucosal adjuvant for oral tolerance induction in type 1 diabetes.
    Bregenholt S; Wang M; Wolfe T; Hughes A; Baerentzen L; Dyrberg T; von Herrath MG; Petersen JS
    Scand J Immunol; 2003 May; 57(5):432-8. PubMed ID: 12753499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rotavirus acceleration of murine type 1 diabetes is associated with increased MHC class I-restricted antigen presentation by B cells and elevated proinflammatory cytokine expression by T cells.
    Pane JA; Webster NL; Zufferey C; Coulson BS
    Virus Res; 2014 Jan; 179():73-84. PubMed ID: 24246305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CXCR4/CXCL12 (SDF-1) signalling pathway protects non-obese diabetic mouse from autoimmune diabetes.
    Aboumrad E; Madec AM; Thivolet C
    Clin Exp Immunol; 2007 Jun; 148(3):432-9. PubMed ID: 17374136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Th1 response in unprimed nonobese diabetic mice to the tyrosine phosphatase-like insulinoma-associated protein 2, an autoantigen in type 1 diabetes.
    Trembleau S; Penna G; Gregori S; Magistrelli G; Isacchi A; Adorini L
    J Immunol; 2000 Dec; 165(12):6748-55. PubMed ID: 11120794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral tolerance induction by mucosal administration of cholera toxin B-coupled antigen involves T-cell proliferation in vivo and is not affected by depletion of CD25+ T cells.
    George Chandy A; Hultkrantz S; Raghavan S; Czerkinsky C; Lebens M; Telemo E; Holmgren J
    Immunology; 2006 Jul; 118(3):311-20. PubMed ID: 16827892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction.
    Suarez-Pinzon W; Rajotte RV; Mosmann TR; Rabinovitch A
    Diabetes; 1996 Oct; 45(10):1350-7. PubMed ID: 8826970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sublingual tolerance induction with antigen conjugated to cholera toxin B subunit induces Foxp3+CD25+CD4+ regulatory T cells and suppresses delayed-type hypersensitivity reactions.
    Sun JB; Cuburu N; Blomquist M; Li BL; Czerkinsky C; Holmgren J
    Scand J Immunol; 2006 Sep; 64(3):251-9. PubMed ID: 16918694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamic acid decarboxylase epitope protects against autoimmune diabetes through activation of Th2 immune response and induction of possible regulatory mechanism.
    Gong Z; Pan L; Le Y; Liu Q; Zhou M; Xing W; Zhuo R; Wang S; Guo J
    Vaccine; 2010 May; 28(24):4052-8. PubMed ID: 20406664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit.
    Sun JB; Rask C; Olsson T; Holmgren J; Czerkinsky C
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7196-201. PubMed ID: 8692968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholera toxin subunit B peptide fusion proteins reveal impaired oral tolerance induction in diabetes-prone but not in diabetes-resistant mice.
    Presa M; Ortiz AZ; Garabatos N; Izquierdo C; Rivas EI; Teyton L; Mora C; Serreze D; Stratmann T
    Eur J Immunol; 2013 Nov; 43(11):2969-79. PubMed ID: 23925934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin B-chain reactive CD4+ regulatory T-cells induced by oral insulin treatment protect from type 1 diabetes by blocking the cytokine secretion and pancreatic infiltration of diabetogenic effector T-cells.
    Bergerot I; Arreaza GA; Cameron MJ; Burdick MD; Strieter RM; Chensue SW; Chakrabarti S; Delovitch TL
    Diabetes; 1999 Sep; 48(9):1720-9. PubMed ID: 10480600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells.
    Mukherjee R; Chaturvedi P; Qin HY; Singh B
    J Autoimmun; 2003 Nov; 21(3):221-37. PubMed ID: 14599847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional oral tolerance in transgenic 2C mice.
    Margenthaler JA; Flye MW
    Surgery; 2005 Aug; 138(2):141-9. PubMed ID: 16153420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of autoimmune diabetes in NOD mice by troglitazone is associated with modulation of ICAM-1 expression on pancreatic islet cells and IFN-gamma expression in splenic T cells.
    Augstein P; Dunger A; Heinke P; Wachlin G; Berg S; Hehmke B; Salzsieder E
    Biochem Biophys Res Commun; 2003 May; 304(2):378-84. PubMed ID: 12711326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.